State board inspections can feel unpredictable, but they follow patterns. Inspectors look for risks to patients, sloppy records, and weak controls. Fines usually come from the same core problems. This guide covers the 10 violations that most often cost pharmacists money and time, and a practical checklist you can use to fix issues before an … Read more
Why do new medicines cost so much, then become far cheaper about 20 years later? The short answer is patents and competition. The long answer explains how the system rewards risky research, how long a patent actually protects a drug, and why prices often collapse once others can legally make the same medicine. Here’s the … Read more
India’s decision to ban several fixed-dose combination (FDC) drugs, including popular cough syrups like Phensedyl, was not a sudden crackdown on household names. It was a long, technical argument about evidence, safety, and how medicines should be approved. This article explains what FDCs are, why the government acted, what the courts said, how industry responded, … Read more
The “refusal to fill” question sits at the intersection of law, ethics, and daily pharmacy practice. Pharmacists must protect patients and comply with strict rules, especially around opioids. Patients need timely care and clear reasons when a prescription is delayed or denied. This article explains when a pharmacist can legally refuse to fill, why, how … Read more
Pharmacy Benefit Manager (PBM) audits are stressful because tiny “clerical errors” can trigger huge clawbacks and fines. The claim paid months ago can be reversed, sometimes for the full amount, because a field on the claim, a date on a label, or a missing signature does not match the record. PBMs argue that accuracy proves … Read more
Pseudoephedrine (PSE) products like Sudafed relieve congestion, but they are also a key ingredient used to make methamphetamine. That dual use is why Congress passed the Combat Methamphetamine Epidemic Act (CMEA). If you sell PSE at a pharmacy, grocery, or convenience store, you have a legal duty to track sales and verify buyers. This article … Read more
“Schedule H1” is a special list of prescription-only medicines under India’s Drugs and Cosmetics Rules, 1945. These drugs include powerful antibiotics, anti‑tuberculosis medicines, and certain sedatives. They can save lives when used correctly, but they also carry real risks: drug‑resistant infections, treatment failure, and dependence. That is why the law is strict. Selling a Schedule … Read more
AI and robotics are changing pharmacy fast. Counting pills, checking interactions, and moving inventory are becoming software and machine jobs. That raises a hard question: by 2030, will machines replace pharmacists? The short answer is no, but the role will change. The work shifts from repetitive tasks to judgment, coaching, and managing complex therapy. To … Read more
India’s drug regulator, the CDSCO, has been clearing a slate of high-impact therapies in 2025. What counts as “revolutionary” is not just a clever mechanism. It’s a therapy that changes outcomes in a big, practical way for Indian patients—by curing or slowing serious disease, reducing hospital load, or enabling care at scale. Below, I explain … Read more
When patients move between settings—admission, transfer, discharge—their medication lists often change. That is when mistakes happen. Medication reconciliation is the process of building one accurate list and making sure every change is intentional, necessary, and understood. It sounds simple. It is not. Done well, it prevents harm, confusion, and readmissions. Done poorly, it lets small … Read more
